tirzepatide discontinuation weight regain study after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Weight regain: a recurring challenge

Tirzepatide targets both GIP and GLP-1 receptors simultaneously, making it a dual agonist

SeekPeptides has compiled the most current research, pharmacy guidelines, and practical storage strategies into one comprehensive resource so you never have to guess about your medication stability again

Diabetologia 2025

Fridays has an F rating with the Better Business Bureau for failing to respond to filed complaints, full pricing is only visible after completing the intake, and the chat advertised as live support is actually AI

I also love that there are no hidden membership fees like those other sites that I mentioned

Multiple reviewers describe being charged for a month of medication that did not ship for weeks